Navigation Links
Microcirculation in Eye May Indicate Coronary Heart Death Risk

A new study suggests that a middle-aged person dying of coronary heart disease can be predicted by examining his eyes for minimized curvature of the arterioles// and venules in the eyes.

Arterioles and venules are small branches of main arteries and veins, and their condition reflects the general state of the smaller blood vessels in the body, or microcirculation.

During the nine years of the study, 78 women (just over 4%) and 114 men (just under 8%) died from coronary heart disease.

Among those aged 49 and up to the age of 75, although relatively uncommon, deaths from coronary heart disease doubled if the venules were wider.

Wider venules have been linked to several risk factors for coronary heart disease, including smoking, systemic inflammation, high total cholesterol and obesity.

In women in this age narrower arterioles were also associated with a 50% increased risk of dying from coronary heart disease.

The authors point out that the numbers involved are small, as fewer people die from heart disease. But signs in the small vessels of the eye appear to be independent predictors of the risk of death from coronary heart disease among those under 75, particularly in women.

Retinal photography may be a useful non-invasive method of assessing this risk, they suggest.

(Source: Eurekalert)
'"/>




Page: 1

Related medicine news :

1. Oxygen Usage During Exercise Could Indicate Heart Problems
2. Oxygen Consumption During Workouts Could Indicate Heart Problems
3. Sleep Disorders Could Indicate Other Medical Problems
4. Calcium Levels Could Indicate Future Heart Disease Risk
5. Inflammation May Indicate Heart Problems
6. Biomarkers May Indicate Alzheimers Disease
7. Living In The Past Indicates Dissatisfaction With Present
8. Intensive Training and Tool Kit, Indicates Adequate Preparation To Combat AIDS.
9. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
10. Researchers Indicate Three-fold Risk of Death after Cesarean Delivery
11. Nitric Oxide Levels In Brain Indicate Sleep
Post Your Comments:
(Date:10/8/2008)...n & Laser Center is well established as a tech...w York City. The facility is living up to its repu... skin resurfacing treatments to receive FDA approv..., New York, NY (PRWEB) Oct...atment industry is in the midst of an unprecedente...
(Date:10/7/2008)...elated Questions for Tonight,s,Presidential Debate...D, the leading source of,health information, today...ndidates, proposed health care policies, located a...candidates, stance on health insurance, medical an...c health issues., The in-depth coverage is just o...
(Date:10/7/2008)...Newswire-USNewswire/ -- IPRO, one of the,nation,s ...ations, has,created a Limited Liability Company (L...t oversight and consulting contracts with managed ...l (http://www.logiqual.com ), is now,officially i...w.newscom.com/cgi-bin/prnh/20081007/DC37283LOGO-a ...
(Date:10/7/2008)...-USNewswire/ -- As the presidential,candidates com...ate, Jean,Berg, a nursing assistant and member of ...waiting to ask John McCain why he wants to tax hea...o afford coverage., Berg has been a nursing assis...are., "It,s the single biggest economic factor in...
Breaking Medicine News(10 mins):Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:IPRO Spins Off Managed Care Review Affiliate 2Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2
...eading player in the Indian drug industry, has rec...Authority (FDA) for three// of its abbreviated new...d will be launching this product in the US through...potex, the Chennai-based company said in a release...
...eople suffering from osteoporosis are not told abo...cording to the research by the University of Weste...alians being affected by osteoporosis, the problem...ly. Dr Charles Inderjeeth from the School of Popu...
...rimination against HIV/AIDS victims will be tabled...or approval.// In the light of the XVI Internatio...i Ramadoss said, "it took a little time, because w...d elaborate discussions with the stakeholders. Hop...
...ed yesterday that a Walkers crisps advertising cam...ntent.// According to the industry watchdog a pro...salt in its crisps to "7% of your guideline daily ...act that the reduction did not apply to all Walker...
Other Medicine News:Health News:Negligence in Osteoporosis treatment 2Health News:Legislation to Prevent Discrimination against HIV/AIDS Victims 2
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
(Date:10/7/2008)... CAMBRIDGE, Mass., Oct. 7 /- Tali... data on several of the Company,s pipeline,candida...ement Workshop in,Basel, Switzerland. The data hig...l models of complement-mediated diseases., "These...vitro studies,presented at the conference, reveal ...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long-...n,s disease patients presented at American College.../- Data from two studies,pr...f Gastroenterology,(ACG) Annual Meeting demonstrat...EGylated anti-TNF alpha (Tumor Necrosis Factor alp...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- A...today that a poster entitled "RDEA119, a Potent,an...in Dextran Sulfate,Sodium (DSS) -- induced Chronic...ollege of Gastroenterology (ACG) 2008 Annual Meeti... data from a preclinical study of,RDEA119, the Com...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
The Stryker AZTEC Shoulder Holder is used for positioning the patients arm during surgery in the lateral position. The shoulder holder is adjustable with respect to height and rotation for all arm po
Medicine Products: